Most recently, Aro Biotherapeutics raised $24.0M in its Early Stage VC (Dec 2022).
- ·Watch Aro Biotherapeutics: the Monday email on marks, rounds and moves
Aro Biotherapeutics round by round
4 roundsHow much has Aro Biotherapeutics raised?
Aro Biotherapeutics has raised $132 million across 4 recorded rounds since 2019. The largest was a $90.3 million later-stage round in Dec 2020; the most recent was a $24 million early-stage round in Dec 2022.
Aro Biotherapeutics has filed 7 Form Ds with the SEC since 2019, most recently in Dec 2022 ($24 million sold to 12 investors).
Aro Biotherapeutics investors
10 investors are on record for Aro Biotherapeutics, including Johnson & Johnson Innovation - JLABS, Johnson & Johnson JJDC, Ridgeback Capital and Avego Management. The early-stage round in Dec 2022 drew 12 investors.
10 investors have backed Aro Biotherapeutics.
Frequently asked about Aro Biotherapeutics
- How much has Aro Biotherapeutics raised?
- Aro Biotherapeutics has raised $131.8M in total across 4 recorded funding rounds.
- When was Aro Biotherapeutics's last funding round?
- Aro Biotherapeutics's most recent recorded round was Early Stage VC in Dec 2022, raising $24.0M.